tirzepatide and kidney stones (Zepbound) showed improved function in obese patients with both chronic kidney disease #heartfailure with preserved ejection fraction, highlighting its potential to address this high-risk patient population. Read more: https tirzepatide and kidney stones Kidney

The right choice often depends on your health history, how your body responds, and what feels sustainable for your lifestyle

At the end of the day, the medication is just a resource and the lifestyle aspect exercising and eating well is incredibly important to sustain over time, she says

A 2026 retrospective study in The Lancet found that postmenopausal women receiving tirzepatide alongside hormone therapy were more than four times as likely to achieve 30% weight loss compared to those on tirzepatide alone: 18% versus 4%

This prevention signal, if confirmed in prospective studies, would have enormous implications for high-risk populations

Pena-Rosas JP, Viteri FE